STAAR Surgical Co Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
STAAR Surgical Co (STAA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $10.04 per share for the 12-month period ending 2026-01-02, per its 10-K filed 2026-03-03.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-03-03
- STAAR Surgical Co share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2026 was $10.04, a 52.46% decline from fiscal 2024.
- STAAR Surgical Co share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $21.12, a 25.53% decline from fiscal 2023.
- STAAR Surgical Co share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $28.36, a 20.52% decline from fiscal 2022.
- STAAR Surgical Co share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $35.68, a 20.85% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|
| 2026-01-02 | $10.04 10-K · filed 2026-03-03 | |
| 2024-12-27 | $21.12 10-K · filed 2026-03-03 | |
| 2023-12-29 | $28.36 10-K · filed 2026-03-03 | |
| 2022-12-30 | $35.68 10-K · filed 2025-02-21 | |
| 2021-12-31 | $45.08 10-K · filed 2024-02-27 | |
| 2021-01-01 | $13.85 10-K · filed 2023-02-23 | |
| 2020-01-03 | $17.95 10-K · filed 2022-02-23 | |
| 2018-12-28 | $11.95 10-K · filed 2021-02-24 | |
| 2017-12-29 | $5.42 10-K · filed 2020-02-26 | |
| 2016-12-30 | $3.77 10-K · filed 2019-02-21 | |
| 2016-01-01 | $4.14 10-K · filed 2018-02-28 | |
| 2015-01-02 | $6.81 10-K · filed 2017-03-02 | |
| 2014-01-03 | $3.51 10-K · filed 2016-03-11 | |
| 2012-12-28 | $6.65 10-K · filed 2015-03-13 | |
| 2012-06-29 | $7.07 10-Q · filed 2012-08-07 | |
| 2011-12-30 | $3.85 10-K · filed 2014-03-12 | |
| 2011-07-01 | $3.59 10-Q · filed 2012-08-07 | |
| 2010-12-31 | $3.13 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |